Total Payments
$25,581
2024 Payments
$879.68
Companies
17
Transactions
82
Medicare Patients
543
Medicare Billing
$54,718
Payment Breakdown by Category
Other$19,100 (74.7%)
Food & Beverage$4,181 (16.3%)
Consulting$2,300 (9.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,100 | 7 | 74.7% |
| Food and Beverage | $4,181 | 73 | 16.3% |
| Consulting Fee | $2,300 | 2 | 9.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $19,822 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,484 | 15 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,291 | 4 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $1,200 | 1 | $0 (2020) |
| Shire North American Group Inc | $268.01 | 6 | $0 (2018) |
| GlaxoSmithKline, LLC. | $260.57 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $185.74 | 2 | $0 (2024) |
| CSL Behring | $177.30 | 6 | $0 (2018) |
| Pharming Healthcare, Inc. | $157.50 | 2 | $0 (2024) |
| Grifols USA, LLC | $155.81 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $879.68 | 8 | AstraZeneca Pharmaceuticals LP ($334.80) |
| 2023 | $482.66 | 7 | AstraZeneca Pharmaceuticals LP ($239.75) |
| 2022 | $329.04 | 5 | AstraZeneca Pharmaceuticals LP ($148.73) |
| 2021 | $481.62 | 7 | AstraZeneca Pharmaceuticals LP ($322.24) |
| 2020 | $1,307 | 2 | AIMMUNE THERAPEUTICS, INC. ($1,200) |
| 2019 | $1,447 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($1,100) |
| 2018 | $6,200 | 31 | Genentech USA, Inc. ($5,653) |
| 2017 | $14,453 | 17 | Genentech USA, Inc. ($14,016) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $101.29 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $100.46 | General |
| 09/18/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $120.44 | General |
| Category: Immunology | ||||||
| 06/13/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $67.31 | General |
| Category: BIOLOGIC | ||||||
| 05/14/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $155.81 | General |
| Category: Immunology and Neurology | ||||||
| 02/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $113.57 | General |
| 02/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $100.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $119.94 | General |
| Category: Respiratory | ||||||
| 12/01/2023 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $43.08 | General |
| 11/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $48.17 | General |
| Category: GENETIC DISEASE | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $75.77 | General |
| Category: Respiratory | ||||||
| 07/31/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $120.90 | General |
| Category: Respiratory | ||||||
| 07/13/2023 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $128.51 | General |
| Category: Oncology | ||||||
| 02/24/2023 | ALK-Abello, Inc | Grastek (Drug), Odactra, Ragwitek | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Allergy and Immunology | ||||||
| 11/11/2022 | ALK-Abello, Inc | Odactra (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Allergy and Immunology | ||||||
| 10/06/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $110.56 | General |
| Category: Respiratory | ||||||
| 05/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $120.81 | General |
| Category: GENETIC DISEASE | ||||||
| 04/10/2022 | ALK-Abello, Inc | Odactra (Drug) | Food and Beverage | In-kind items and services | $40.50 | General |
| Category: Allergy and Immunology | ||||||
| 02/27/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $38.17 | General |
| 11/07/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Immunology | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $91.44 | General |
| Category: Respiratory | ||||||
| 10/07/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.01 | General |
| 09/15/2021 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $90.19 | General |
| Category: BIOLOGIC | ||||||
| 07/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 96 | 110 | $43,132 | $10,615 |
| 2022 | 3 | 111 | 145 | $45,640 | $10,588 |
| 2021 | 3 | 162 | 275 | $75,596 | $18,229 |
| 2020 | 5 | 174 | 219 | $64,572 | $15,287 |
Total Patients
543
Total Services
749
Medicare Billing
$54,718
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 67 | $23,048 | $6,065 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $14,924 | $3,553 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 15 | $5,160 | $996.84 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 65 | $22,360 | $5,610 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $21,320 | $4,638 | 21.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 14 | 40 | $1,960 | $339.93 | 17.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 93 | $31,992 | $8,785 | 27.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $30,989 | $7,113 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 22 | $7,568 | $1,529 | 20.2% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 15 | 103 | $5,047 | $801.52 | 15.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 54 | 54 | $28,782 | $6,414 | 22.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 65 | $22,360 | $5,144 | 23.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 24 | $2,880 | $1,485 | 51.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 18 | 19 | $6,536 | $970.37 | 14.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,760 | $953.13 | 54.2% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 15 | 46 | $2,254 | $320.97 | 14.2% |
About Dr. David Khan, MD
Dr. David Khan, MD is a Allergy & Immunology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891757688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Khan, MD has received a total of $25,581 in payments from pharmaceutical and medical device companies, with $879.68 received in 2024. These payments were reported across 82 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,100).
As a Medicare-enrolled provider, Khan has provided services to 543 Medicare beneficiaries, totaling 749 services with total Medicare billing of $54,718. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Dallas, TX
- Active Since 04/05/2006
- Last Updated 04/03/2008
- Taxonomy Code 207RA0201X
- Entity Type Individual
- NPI Number 1891757688
Products in Payments
- Xolair (Biological) $19,622
- PALFORZIA (Biological) $1,200
- ICLUSIG (Drug) $1,100
- TEZSPIRE (Biological) $408.52
- FASENRA (Biological) $317.17
- CUVITRU (Biological) $269.09
- NUCALA (Biological) $260.57
- FASENRA (Drug) $210.72
- DUPIXENT (Biological) $208.27
- TAKHZYRO (Biological) $189.82
- Haegarda (Biological) $177.30
- RUCONEST (Biological) $157.50
- Xembify (Biological) $155.81
- MONJUVI (Drug) $128.51
- Bavencio (Biological) $91.67
- FEVIPIPRANT (Drug) $85.28
- Odactra (Drug) $59.50
- Grastek (Drug) $50.00
- Orladeyo (Drug) $25.68
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $16.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Dallas
Richard Wasserman, Md, Phd, MD, PHD
Allergy & Immunology — Payments: $635,979
Allergy & Immunology $635,979
Matthew Feldman, Md, MD
Allergy & Immunology — Payments: $457,527
Allergy & Immunology $457,527
Lara Gross, Md, MD
Allergy & Immunology — Payments: $98,292
Allergy & Immunology $98,292
Dr. Sonak Daulat, M.d, M.D
Allergy & Immunology — Payments: $69,124
Allergy & Immunology $69,124
Dr. Elliot Ginchansky, M.d, M.D
Allergy & Immunology — Payments: $55,842
Allergy & Immunology $55,842
Dr. Sandeep Reddy, Md, MD
Allergy & Immunology — Payments: $36,350
Allergy & Immunology $36,350